Hodges Capital Management’s Novavax NVAX Stock Holding History

Hodges Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$72K	–	220
2023 Q3	$72K	Buy	+10,000	New	+$79.9K	0.01%	209
2021 Q4	–	Sell	-2,500	Closed	-$518K	–	252
2021 Q3	$518K	Buy	2,500 +500	+25%	+$110K	0.04%	185
2021 Q2	$425K	Hold	2,000	–	–	0.05%	182
2021 Q1	$363K	Hold	2,000	–	–	0.05%	176
2020 Q4	$223K	Hold	2,000	–	–	0.04%	192
2020 Q3	$217K	Sell	2,000 -1,000	-33%	-$122K	0.04%	182
2020 Q2	$250K	Buy	+3,000	New	+$115K	0.05%	168

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hodges Capital Management's NVAX Position: Q4 2023 in Review

Hodges Capital Management sold out of Novavax (NVAX) in Q4 2023, closing a stake of 10,000 shares — an estimated $72K sold.

Hodges Capital Management first reported a position in NVAX in Q2 2020 and held it in 7 quarters. The position peaked at $518K in Q3 2021. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

Hodges Capital Management reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
Hodges Capital Management sold 10,000 Novavax shares in Q4 2023, an estimated $72K.
Hodges Capital Management first reported a position in Novavax in Q2 2020 and held it in 7 quarters.
Hodges Capital Management's Novavax position peaked at $518K in Q3 2021.
199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on Hodges Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.